Trial Profile
Safety and Immunogenicity of Live Attenuated Herpes Zoster Vaccine in Patients Undergoing Living Donor Kidney Transplantations.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Jun 2022
Price :
$35
*
At a glance
- Drugs Varicella zoster virus vaccine live (Primary)
- Indications Herpes zoster
- Focus Pharmacodynamics
- 26 May 2022 Status changed from active, no longer recruiting to completed.
- 26 May 2015 Planned End Date changed from 1 Dec 2013 to 1 Dec 2016 as per ClinicalTrials.gov record.
- 26 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.